The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 262.25%.However, over the last six months, we can see a weaker performance of 205.18%. Over the last 30 days, the price of HOTH has fallen by 225.13%. And in the last five days, it has surged by 256.06%.
Hoth Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $1.69 on 01/07/25 and the lowest value was $0.58 on 08/08/24.
52-week price history of HOTH Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Hoth Therapeutics Inc’s current trading price is 60.36% away from its 52-week high, while its distance from the 52-week low is 367.24%. The stock’s price range during this period has varied between$0.58 and $1.69. The Hoth Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 302.07 million for the day, a figure considerably higher than their average daily volume of 1.11 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Hoth Therapeutics Inc (HOTH) has experienced a quarterly rise of 226.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.71M and boasts a workforce of 6 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8738, with a change in price of +2.5660. Similarly, Hoth Therapeutics Inc recorded 5,451,729 in trading volume during the last 100 days, posting a change of +424.20%.
HOTH’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for HOTH stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
HOTH Stock Stochastic Average
Hoth Therapeutics Inc’s raw stochastic average for the past 50 days is presently 79.70%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 79.70%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 64.54% and 50.22%, respectively.
